RSS
Hemlibra
EC approves Roche’s prophylaxis treatment for haemophilia A with factor VIII inhibitors
The European Commission (EC) has approved Roche’s routine prophylactic treatment in people with haemophilia A with factor VIII inhibitors, Hemlibra (emicizumab). Read more
CHMP adopts positive opinion for Roche’s prophylactic treatment, Hemlibra
The EU Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Hemlibra (emicizumab) — Roche’s prophylactic treatment for people with haemophilia A with inhibitors. Read more
